A

Absci Corporation

Absci Corporation is a biotechnology company developing ABS-201, a drug for pattern hair loss and endometriosis. The company announced positive early clinical trial data for ABS-201, showing it was well-tolerated and had a long-lasting presence in the body. This news coincided with a $100 million stock offering to fund further development.

Total raised
Undisclosed
tracked to date
Latest round
$100 million
Sep 5, 2026
Known investors
6
led by Eli Lilly & Company

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 USA Funding Report

Read the Q3 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 USA Funding Report</a>

Funding history

  1. 1
    $100 millionSep 5, 2026

    Led by Eli Lilly & Company

    Announcement ↗

Investors in Absci Corporation

Backers from this company's tracked funding rounds.

  • EEli Lilly & CompanyLead investorVC firm
  • AAdageVC firm
  • BBVF PartnersVC firm
  • CColumbia ThreadneedleVC firm
  • IInvusVC firm
  • RRedmileVC firm

Absci Corporation in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile